173 related articles for article (PubMed ID: 32620662)
1. Pembrolizumab and Radiotherapy for Platinum-refractory Recurrent Uterine Carcinosarcoma With an Abscopal Effect: A Case Report.
Yano M; Aso S; Sato M; Aoyagi Y; Matsumoto H; Nasu K
Anticancer Res; 2020 Jul; 40(7):4131-4135. PubMed ID: 32620662
[TBL] [Abstract][Full Text] [Related]
2. Exceptional Response of Cryoablation Followed by Pembrolizumab in a Patient with Metastatic Cervical Carcinosarcoma with High Tumor Mutational Burden: A Case Report.
Zhu B; Liu Y; Li J; Diao L; Shao L; Han-Zhang H; Zhang L; Kang Q; Yang W
Oncologist; 2020 Jan; 25(1):15-18. PubMed ID: 31848313
[TBL] [Abstract][Full Text] [Related]
3. [Uterine carcinosarcoma].
Serkies K; Jassem J
Ginekol Pol; 2012 Aug; 83(8):609-12. PubMed ID: 23342885
[TBL] [Abstract][Full Text] [Related]
4. Impact of treatment strategies on local control and survival in uterine carcinosarcomas in Turkey.
Kucukoztas N; Dizdar O; Rahatli S; Dursun P; Yalcin S; Altundağ Ö; Ozen O; Reyhan NH; Tarhan C; Yildiz F; Ayhan A
Asian Pac J Cancer Prev; 2013; 14(5):2959-62. PubMed ID: 23803061
[TBL] [Abstract][Full Text] [Related]
5. A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.
Ang JE; Shah RN; Everard M; Keyzor C; Coombes I; Jenkins A; Thomas K; A'Hern R; Jones RL; Blake P; Gabra H; Hall G; Gore ME; Kaye SB
Ann Oncol; 2009 Nov; 20(11):1787-93. PubMed ID: 19542250
[TBL] [Abstract][Full Text] [Related]
6. Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma.
Kao CH; Liu CT; Lin H; Huang YC; Lan J; Ou YC; Fu HC; Wu CH
Front Immunol; 2022; 13():1079253. PubMed ID: 36591227
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma.
Barney BM; Petersen IA; Dowdy SC; Bakkum-Gamez JN; Haddock MG
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):191-7. PubMed ID: 21985942
[TBL] [Abstract][Full Text] [Related]
8. Endometrial carcinosarcoma.
Bogani G; Ray-Coquard I; Concin N; Ngoi NYL; Morice P; Caruso G; Enomoto T; Takehara K; Denys H; Lorusso D; Coleman R; Vaughan MM; Takano M; Provencher DM; Sagae S; Wimberger P; Póka R; Segev Y; Kim SI; Kim JW; Candido Dos Reis FJ; Ramirez PT; Mariani A; Leitao M; Makker V; Abu-Rustum NR; Vergote I; Zannoni G; Tan D; McCormack M; Paolini B; Bini M; Raspagliesi F; Benedetti Panici P; Di Donato V; Muzii L; Colombo N; Pignata S; Scambia G; Monk BJ
Int J Gynecol Cancer; 2023 Feb; 33(2):147-174. PubMed ID: 36585027
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.
Pectasides D; Pectasides E; Papaxoinis G; Xiros N; Sykiotis C; Papachristodoulou A; Tountas N; Panayiotides J; Economopoulos T
Gynecol Oncol; 2008 Sep; 110(3):299-303. PubMed ID: 18602677
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
Rauh-Hain JA; Starbuck KD; Meyer LA; Clemmer J; Schorge JO; Lu KH; Del Carmen MG
Gynecol Oncol; 2015 Oct; 139(1):84-9. PubMed ID: 26307402
[TBL] [Abstract][Full Text] [Related]
11. Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: a case report.
Kahraman K; Ortac F; Kankaya D; Aynaoglu G
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):89-92. PubMed ID: 22482976
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit.
Otsuki A; Watanabe Y; Nomura H; Futagami M; Yokoyama Y; Shibata K; Kamoi S; Arakawa A; Nishiyama H; Katsuta T; Kudaka W; Shimada M; Sato N; Kotera K; Katabuchi H; Yaegashi N
Int J Gynecol Cancer; 2015 Jan; 25(1):92-7. PubMed ID: 25347097
[TBL] [Abstract][Full Text] [Related]
13. Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report.
Martin-Romano P; Jurado M; Idoate MA; Arbea L; Hernandez-Lizoain JL; Cano D; Paramo JA; Martin-Algarra S
J Med Case Rep; 2017 Apr; 11(1):115. PubMed ID: 28424084
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.
Dandamudi RK; Aslam S; Walji N; El-Modir A; Fernando I
Anticancer Res; 2015 Sep; 35(9):4841-7. PubMed ID: 26254376
[TBL] [Abstract][Full Text] [Related]
15. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.
Matsuo K; Takazawa Y; Ross MS; Elishaev E; Podzielinski I; Yunokawa M; Sheridan TB; Bush SH; Klobocista MM; Blake EA; Takano T; Matsuzaki S; Baba T; Satoh S; Shida M; Nishikawa T; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Fujiwara K; Hazama Y; Kadogami D; Moffitt MN; Takeuchi S; Nishimura M; Iwasaki K; Ushioda N; Johnson MS; Yoshida M; Hakam A; Li SW; Richmond AM; Machida H; Mhawech-Fauceglia P; Ueda Y; Yoshino K; Yamaguchi K; Oishi T; Kajiwara H; Hasegawa K; Yasuda M; Kawana K; Suda K; Miyake TM; Moriya T; Yuba Y; Morgan T; Fukagawa T; Wakatsuki A; Sugiyama T; Pejovic T; Nagano T; Shimoya K; Andoh M; Shiki Y; Enomoto T; Sasaki T; Fujiwara K; Mikami M; Shimada M; Konishi I; Kimura T; Post MD; Shahzad MM; Im DD; Yoshida H; Omatsu K; Ueland FR; Kelley JL; Karabakhtsian RG; Roman LD
Ann Oncol; 2016 Jul; 27(7):1257-66. PubMed ID: 27052653
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.
Yoo HJ; Lim MC; Lim S; Park JY; Kang S; Park SY; Seo SS
Arch Gynecol Obstet; 2012 Dec; 286(6):1529-35. PubMed ID: 22825691
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin and Pembrolizumab Chemoimmunotherapy Achieves Remission in Recurrent, Metastatic Sebaceous Carcinoma.
Kodali S; Tipirneni E; Gibson PC; Cook D; Verschraegen C; Lane KA
Ophthalmic Plast Reconstr Surg; 2018; 34(5):e149-e151. PubMed ID: 29979269
[TBL] [Abstract][Full Text] [Related]
18. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.
Wolfson AH; Brady MF; Rocereto T; Mannel RS; Lee YC; Futoran RJ; Cohn DE; Ioffe OB
Gynecol Oncol; 2007 Nov; 107(2):177-85. PubMed ID: 17822748
[TBL] [Abstract][Full Text] [Related]
19. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.
Hensley ML
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):773-82. PubMed ID: 21752717
[TBL] [Abstract][Full Text] [Related]
20. Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature.
Carausu M; Beddok A; Langer A; Girard N; Bidard FC; Massiani MA; Ricard D; Cabel L
J Immunother Cancer; 2019 Nov; 7(1):317. PubMed ID: 31753021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]